FindTrial
Sign In

An observational study to see whether Neurodevelopmental outcome is affected at 18-24 months of age in Neonates with Mild HIE and borderline low Apgar without therapeutic hypothermia

Neurodevelopmental outcome at 18-24 months of age in Neonates with Mild HIE and borderline low Apgar without therapeutic hypothermia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/01/022958
Enrollment
30
Registered
2020-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P00-P04- Newborn affected by maternal factors and by complications of pregnancy, labor, and delivery

Interventions

None listed

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Babies with mild hypoxic Ischaemic Encephalopathy(HIE)/HIE stage I/ Apgar score of 5 to 7 at 5 mins those who have not received therapeutic hypothermia

Exclusion criteria

Exclusion criteria: HIE stage I or mild HIE/Apgar 5 to 7 at 5 mins those who received therapeutic hypothermia

Design outcomes

Primary

MeasureTime frame
Neurodevelopmental outcome at 18-24 months of age using BSID IIITimepoint: 18 to24 months of age—

Secondary

MeasureTime frame
NoneTimepoint: None—

Countries

India

Contacts

Public ContactJayashree Purkayastha

Kasturba Medical College

jaya.p@manipal.edu9886249133

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026